Target intelligence / Profile preview

Cellular membranes, reactive oxygen species, and polyunsaturated fatty acids in retinal cells

Molecular classification
Lipid, Reactive Oxygen Species, Cellular Component
01

Overview

The interplay between cellular membranes, reactive oxygen species (ROS), and polyunsaturated fatty acids (PUFAs) in retinal cells is a critical factor in retinal health and disease [Beatty et al., 2000]. Retinal cells, particularly photoreceptors, contain high concentrations of PUFAs like docosahexaenoic acid (DHA) within their outer segment membranes, which are essential for maintaining the fluidity required for rapid phototransduction [SanGiovanni & Chew, 2005]. However, these membranes are highly susceptible to lipid peroxidation due to the high oxygen tension, constant light exposure, and the presence of photosensitizers in the retina. ROS-mediated damage to these lipids leads to the formation of toxic byproducts like 4-hydroxynonenal (4-HNE) and the accumulation of lipofuscin in the retinal pigment epithelium (RPE) [Sparrow et al., 2012]. This process is a primary driver of degenerative conditions such as age-related macular degeneration (AMD) and Stargardt disease. Therapeutic strategies focus on neutralizing ROS with antioxidants or reinforcing PUFAs against oxidation using deuterated analogs (D-PUFAs) to maintain membrane integrity and cell viability [Heidt et al., 2020].

Other names
Retinal lipid peroxidationRetinal oxidative stressPUFA-ROS interaction in the retinaRetinal membrane lipid peroxidation
02

Mechanism of action

Antioxidants neutralize reactive oxygen species (ROS) to prevent the initiation of lipid peroxidation. Deuterated polyunsaturated fatty acids (D-PUFAs) stabilize carbon-hydrogen bonds against abstraction by free radicals, thereby inhibiting the chain reaction of lipid peroxidation in retinal membranes.

03

Biological functions

Membrane fluidityPhototransductionOxidative stress responseLipid metabolism
04

Disease associations

Age-related macular degenerationStargardt diseaseRetinitis pigmentosaDiabetic retinopathyLeber congenital amaurosis
05

Safety considerations

Potential pro-oxidant effects of high-dose antioxidantsInterference with physiological ROS signaling pathwaysChallenges in blood-retinal barrier penetration for therapeutic agentsLong-term safety of incorporating modified lipids into neural membranes
06

Interacting drugs

Docosahexaenoic acid

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-IsoprostaneLipofuscin accumulationFundus autofluorescence (FAF)

Beyond the preview

Go deeper on Cellular membranes, reactive oxygen species, and polyunsaturated fatty acids in retinal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membranes, reactive oxygen species, and polyunsaturated fatty acids in retinal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call